Personalising laboratory medicine in the 'real world': Assessing clinical utility, by clinical indication, of serum total B12 and Active-B12® (holotranscobalamin) in the diagnosis of vitamin B12 deficiency

被引:2
作者
Murphy, Michael J. [1 ]
Brandie, Fiona [2 ]
Ebare, Mildred [3 ]
Harrison, Michelle [4 ]
Dow, Ellie [1 ]
Bartlett, William A. [5 ]
Craig, David [6 ]
机构
[1] Ninewells Hosp & Med Sch, Dept Biochem Med, Dundee, Scotland
[2] Aberdeen Royal Infirm, Dept Biochem, Aberdeen, Scotland
[3] NHS Educ Scotland, Gen Practice Training, Dundee, Scotland
[4] Ninewells Hosp & Med Sch, Dept Haematol, Dundee, Scotland
[5] NHS Natl Serv Scotland, Edinburgh, Midlothian, Scotland
[6] Axis Shield Diagnost Ltd, Dundee, Scotland
关键词
Evidence-based medicine; clinical utility; Youden cut-offs; diagnostic uncertainty; electronic test requesting; ‘ real-world’ setting; vitamin B-12; METHYLMALONIC ACID; OLDER-PEOPLE; HOMOCYSTEINE; RISK; BIOMARKERS; COBALAMIN; DISEASE;
D O I
10.1177/00045632211003605
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Assessing the pre- and post-test probability of disease in the context of routine health care is challenging. We wished to study how test performance parameters relating to clinical utility vary by clinical indication in a 'real-world' setting. Methods The diagnostic accuracy of serum total B-12 and Active-B-12 (R) (holotranscobalamin) was evaluated in a primary care population, using serum methylmalonic acid as the reference standard. We used electronic requesting to establish the clinical indication for each request. Routine requests from primary care for serum total B-12 were included if creatinine was also measured and estimated glomerular filtration rate was at least 60 mL/min/1.73 m(2). Results Clinical indications included peripheral neuropathy (n = 168), anaemia (n = 168), cognitive decline (n = 125), suspected dietary deficiency (n = 76), other (n = 362). For peripheral neuropathy, the area under the receiver operator curve +/- 95% confidence interval (AUC +/- CI) was 0.63 (0.54-0.71) (P = 0.002) for total B-12 and 0.68 (0.60-0.77) (P < 0.0001) for Active-B-12 (R). For anaemia, AUC +/- CI was 0.56 (0.47-0.66) (P = 0.10) for total B-12 and 0.69 (0.59-0.78) (P < 0.0001) for Active-B-12 (R). For cognitive decline, AUC +/- CI was 0.54 (0.43-0.65) (P = 0.26) for total B-12 and 0.69 (0.58-0.80) (P = 0.0002) for Active-B-12 (R). The pre-post-test change in probability of disease varied by clinical indication. Conclusion Combining diagnostic accuracy studies and electronic testing in a 'real-world' setting allows clinical utility to be assessed by clinical indication. Wider application of this would permit more personalised laboratory medicine. In this study, diagnostic performance of total B-12 and Active-B-12 (R) varied across all indications. Active-B-12 (R) provided better discrimination, but this may have reflected the cut-offs used.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 21 条
[1]   Low vitamin B-12 status and risk of cognitive decline in older adults [J].
Clarke, Robert ;
Birks, Jacqueline ;
Nexo, Ebba ;
Ueland, Per M. ;
Schneede, Joern ;
Scott, John ;
Molloy, Anne ;
Evans, John Grimley .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (05) :1384-1391
[2]   Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalamin [J].
Clarke, Robert ;
Sherliker, Paul ;
Hin, Harold ;
Nexo, Ebba ;
Hvas, Anne Mette ;
Schneede, Joern ;
Birks, Jacqueline ;
Ueland, Per M. ;
Emmens, Kathleen ;
Scott, John M. ;
Molloy, Anne M. ;
Evans, John Grimley .
CLINICAL CHEMISTRY, 2007, 53 (05) :963-970
[3]   Combined indicator of vitamin B12 status: modification for missing biomarkers and folate status and recommendations for revised cut-points [J].
Fedosov, Sergey N. ;
Brito, Alex ;
Miller, Joshua W. ;
Green, Ralph ;
Allen, Lindsay H. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (08) :1215-1225
[4]   Vitamin B12 deficiency [J].
Green, Ralph ;
Allen, Lindsay H. ;
Bjorke-Monsen, Anne-Lise ;
Brito, Alex ;
Gueant, Jean-Louis ;
Miller, Joshua W. ;
Molloy, Anne M. ;
Nexo, Ebba ;
Stabler, Sally ;
Toh, Ban-Hock ;
Ueland, Per Magne ;
Yajnik, Chittaranjan .
NATURE REVIEWS DISEASE PRIMERS, 2017, 3
[5]   Laboratory assessment of vitamin B12 status [J].
Harrington, Dominic J. .
JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (02) :168-173
[6]   Screening for metabolic vitamin B12 deficiency by holotranscobalamin in patients suspected of vitamin B12 deficiency: a multicentre study [J].
Heil, Sandra G. ;
de Jonge, Robert ;
de Rotte, Maurits C. F. J. ;
van Wijnen, Merel ;
Heiner-Fokkema, Rebecca M. R. ;
Kobold, Anneke C. Muller ;
Pekelharing, J. Maurits M. ;
Adriaansen, Henk J. ;
Sanders, Edward ;
Trienekens, Paul H. ;
Rammeloo, Ton ;
Lindeman, Jan .
ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 :184-189
[7]   Homocysteine and holotranscobalamin and the risk of Alzheimer disease A longitudinal study [J].
Hooshmand, B. ;
Solomon, A. ;
Kareholt, I. ;
Leiviska, J. ;
Rusanen, M. ;
Ahtiluoto, S. ;
Winblad, B. ;
Laatikainen, T. ;
Soininen, H. ;
Kivipelto, M. .
NEUROLOGY, 2010, 75 (16) :1408-1414
[8]   Assessing biomarker status of vitamin B12 in the laboratory: no simple solution [J].
Hughes, Catherine F. ;
McNulty, Helene .
ANNALS OF CLINICAL BIOCHEMISTRY, 2018, 55 (02) :188-189
[9]   Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study [J].
Kivipelto, M. ;
Annerbo, S. ;
Hultdin, J. ;
Backman, L. ;
Viitanen, M. ;
Fratiglioni, L. ;
Lokk, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (07) :808-813
[10]   Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly [J].
Lewerin, C. ;
Ljungman, S. ;
Nilsson-Ehle, H. .
JOURNAL OF INTERNAL MEDICINE, 2007, 261 (01) :65-73